Connect with us

Hi, what are you looking for?

[t4b-ticker]

India

Shilpa Medicare ties up with Dr Reddy’s to produce Sputnik V Covid vaccine

New Delhi: Drug firm Shilpa Medicare announced on Monday that its arm has reached a definitive agreement with Dr Reddy’s Laboratories for manufacturing of Russian coronavirus vaccine Sputnik V.

Sputnik Light (Credit: @sputnikvaccine)

New Delhi: Drug firm Shilpa Medicare announced on Monday that its arm has reached a definitive agreement with Dr Reddy’s Laboratories for manufacturing of Russian coronavirus vaccine Sputnik V.

“The company, via its wholly owned subsidiary Shilpa Biologicals Pvt Ltd (SBPL), has entered into a three year definitive agreement with Dr Reddy’s Laboratories for production-supply of the Sputnik V vaccine from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka,” Shilpa Medicare said in a regulatory filing.

Representational Image (Source: PTI)

ALSO READ: Coronavirus vaccination for 18-44 age group begins in Kerala

The company also added that their targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses (50 million of component 1 and 50 million of component 2), from the date of start of commercial production.

Shilpa Medicare also added that Dr Reddy’s will facilitate the transfer of the sputnik technology to SBPL.

Under the agreement, SBPL will be responsible for manufacture of the vaccine, while Dr Reddy’s is responsible for distribution/marketing of the vaccine in its marketing territories.

Shilpa Medicare said the companies are also exploring the option to manufacture Sputnik Light, a single dose version of the vaccine in the near future.

Reddy’s Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Deepak Sapra, a senior executive of the drug-maker, taking the first shot.

ALSO READ: Cyclone Tauktae: Amit Shah speaks to Goa CM, assures full assistance

The vaccine is priced at Rs 948, with five per cent GST per dose (retail price of Rs 995.40).

Advertisement. Scroll to continue reading.

The first consignment of imported doses of the Sputnik V vaccine from Russian Direct Investment Fund (RDIF) landed in India on May 1, and received regulatory clearance from the Central Drugs Laboratory.

You May Also Like

India

SRINAGAR, Jammu and Kashmir – Sixty-year-old Dinesh Mondal and his ice cream cart have been a fixture on the streets of Srinagar for decades....

India

On October 19, 2020, the office of the Kashmir Times, located in the Press Enclave in Srinagar, was sealed by the Estates Department of...

India

Indian Security Forces, who have begun an anti-terror operation in Jammu and Kashmir, have continued to flush out terrorists in the valley amid a...

India

Amarinder Singh also said that he is looking at alliance with breakaway Akali groups ahead of next year's assembly elections in the state.

Advertisement